Page 39 - IJSA, Vol. 6, No 1, 2023
P. 39

International Journal of Science Annals, Vol. 6, No. 1, 2023
                      рrint ISSN: 2617-2682; online ISSN: 2707-3637; DOI:10.26697/ijsa

            metabolism. Furthermore, the Apo B100/ Apo A1 ratio   Chobanian, A. V.,   Bakris, G. L.,   Black, H. R.,
            may  be  used  as  a  complementary  marker  for  the    Cushman, W. C.,   Green, L. A.,   Izzo, J. L.,
            prediction  of  the  risk  of  cardiovascular  disease  in   Jones, D. W.,   Materson, B. J.,   Oparil, S.,
            essential hypertension subjects.                         Wright, J. T.,  &  Roccella, E. J.  (2003).  The
            Prospects  for  further  research  include  establishing  a   seventh report of the Joint National Committee on
            causal   relationship   between   dyslipidemia   and     prevention,  detection,  evaluation,  and  treatment
            hypertension;  identifying  changes  in  the  lipid  profile   of high blood pressure: the JNC 7 report. JAMA,
            caused by diet, physical activity, medications, or other   289(19),                    2560–2572.
            influences;  and  determining  the  relationship  of  lipid   https://doi.org/10.1001/jama.289.19.2560
            parameters and apolipoproteins with other cardiovascular   Ferreira, I.,   van   de   Laar, R. J.,   Prins, M. H.,
            risk factors.                                            Twisk, J. W., & Stehouwer, C. D. (2012). Carotid
                                                                     stiffness in young adults: A life-course analysis of
            Ethical Approval                                         its early determinants: the Amsterdam growth and
            Institutional  Ethical  Committee  approval  was  obtained   health  longitudinal  study.  Hypertension,  59(1),
            from the institution (Reference No: IEC/MC/2020/459,     54–61.
            dated 08/01/2021).                                       https://doi.org/10.1161/HYPERTENSIONAHA.
                                                                     110.156109
            Funding Source                                     Forouzanfar, M. H.,   Liu, P.,   Roth, G. A.,   Ng, M.,
            This  research  did  not  receive  any  outside  funding  or   Biryukov, S.,   Marczak, L.,   Alexander, L.,
            support.                                                 Estep, K.,  Hassen  Abate, K.,  Akinyemiju, T. F.,
                                                                     Ali, R.,   Alvis-Guzman, N.,   Azzopardi, P.,
            References                                               Banerjee, A.,   Bärnighausen, T.,   Basu, A.,
            Albucher, J. F.,  Ferrieres, J.,  Ruidavets, J. B.,  Guiraud-  Bekele, T., Bennett, D. A., Biadgilign, S., Catalá-
                  Chaumeil, B., Perret, B. P., & Chollet, F. (2000).   López, F., … Murray, C. J. (2017). Global burden
                  Serum  lipids  in  young  patients  with  ischaemic   of hypertension and systolic blood pressure of at
                  stroke:  A  case-control  study.  Journal  of      least  110  to  115  mm  Hg,  1990-2015.  JAMA,
                  Neurology, Neurosurgery, and Psychiatry, 69(1),    317(2),                         165–182.
                  29–33. https://doi.org/10.1136/jnnp.69.1.29        https://doi.org/10.1001/jama.2016.19043
            AlGhatrif, M.,  Strait, J. B.,  Morrell, C. H.,  Canepa, M.,   Friedewald, W. T.,  Levy, R. I.,  &  Fredrickson, D. S.
                  Wright, J.,  Elango, P.,  Scuteri, A.,  Najjar, S. S.,   (1972).  Estimation  of  the  concentration  of  low-
                  Ferrucci, L.,   &   Lakatta, E. G.   (2013).       density lipoprotein cholesterol in plasma, without
                  Longitudinal trajectories of arterial stiffness and   use  of  the  preparative  ultracentrifuge.  Clinical
                  the  role  of  blood  pressure:  The  Baltimore    Chemistry,        18(6),        499–502.
                  longitudinal study of aging. Hypertension, 62(5),   https://doi.org/10.1093/clinchem/18.6.499
                  934–941.                                     Gotto, A. M. (2005). Evolving concepts of dyslipidemia,
                  https://doi.org/10.1161/HYPERTENSIONAHA.           atherosclerosis,  and  cardiovascular  disease:  The
                  113.01445                                          Louis F. Bishop lecture. Journal of the American
            Anchala, R.,   Kannuri, N. K.,   Pant, H.,   Khan, H.,   College  of  Cardiology,  46(7),  1219–1224.
                  Franco, O. H.,   Di   Angelantonio, E.,   &        https://doi.org/10.1016/j.jacc.2005.06.059
                  Prabhakaran, D. (2014). Hypertension in India: a   Haidari, M.,   Moghadam, M.,   Chinicar, M.,
                  systematic   review   and   meta-analysis   of     Ahmadieh, A.,   &    Doosti, M.   (2001).
                  prevalence,   awareness,   and   control   of      Apolipoprotein B as the best predictor of coronary
                  hypertension.  Journal  of  Hypertension,  32(6),   artery disease in Iranian normolipidemic patients.
                  1170–1177.                                         Clinical   Biochemistry,   34(2),   149–155.
                  https://doi.org/10.1097/HJH.0000000000000146       https://doi.org/10.1016/s0009-9120(01)00192-8
            Barter, P. J.,    Nicholls, S.,      Rye, K. A.,   Halperin, R. O.,  Sesso, H. D.,  Ma, J.,  Buring, J. E.,
                  Anantharamaiah, G. M.,   Navab, M.,   &            Stampfer, M. J.,   &   Gaziano, J. M.   (2006).
                  Fogelman, A. M.   (2004).   Antiinflammatory       Dyslipidemia   and   the   risk   of   incident
                  properties of HDL. Circulation Research, 95(8),    hypertension in men. Hypertension, 47(1), 45–50.
                  764–772.                                           https://doi.org/10.1161/01.HYP.0000196306.42418.0e
                  https://doi.org/10.1161/01.RES.0000146094.59640.13   Harvey, J. M.,  &  Beevers, D. G.  (1990).  Biochemical
            Bhavani, B. A.,   Padma, T.,   Sastry, B. K.,   &        investigation of hypertension. Annals of Clinical
                  Reddy, N. K.  (2003).  Plasma  lipoprotein  (a)    Biochemistry,      27(4),       287–296.
                  levels  in  patients  with  untreated  essential   https://doi.org/10.1177/000456329002700403
                  hypertension. Indian Journal of Human Genetics,   Hausmann, D.,   Johnson, J. A.,   Sudhir, K.,
                  9(2),  65–68.  https://www.ijhg.com/article-0971-  Mullen, W. L.,  Friedrich, G.,  Fitzgerald, P. J.,
                  6866-2003-9-2-65-68-bhavani/                       Chou, T. M.,    Ports, T. A.,   Kane, J. P.,
            Carmena, R.,  Duriez, P.,  &  Fruchart, J. C.  (2004).   Malloy, M. J.,   &   Yock, P. G.   (1996).
                  Atherogenic   lipoprotein   particles   in         Angiographically  silent  atherosclerosis  detected
                  atherosclerosis.  Circulation,  109(23  Suppl. 1),   by  intravascular  ultrasound  in  patients  with
                  III2–III7.                                         familial  hypercholesterolemia  and  familial
                  https://doi.org/10.1161/01.CIR.0000131511.50734.44
                                                           37
   34   35   36   37   38   39   40   41   42   43   44